Skip directly to page options Skip directly to A-Z link

Volume 10, Number 1—January 2004

Synopsis

Fungal Biofilms and Drug Resistance

Mary Ann Jabra-Rizk*Comments to Author , William A. Falkler*, and Timothy F. Meiller*
Author affiliations: *Dental School, University of Maryland, Baltimore, Maryland, USA

Main Article

Figure 1

Illustration of biofilm development in Candida albicans and C. dubliniensis; A, early 0–11 h; B, intermediate 12–30 h; C, mature 38–72 h; FS, flat surface; YC, yeast cell; H, hyphae; EP, exopolymeric matrix.

Figure 1. Illustration of biofilm development in Candida albicans and C. dubliniensis; A, early 0–11 h; B, intermediate 12–30 h; C, mature 38–72 h; FS, flat surface; YC, yeast cell; H, hyphae; EP, exopolymeric matrix.

Download

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external